Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide. | EJHaem | 2023 | 38024610 | PubTator, text mining | PubMed |
| Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation. | Pharmgenomics Pers Med | 2023 | 38023823 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. | Medicina (Kaunas) | 2023 | 38004002 | PubTator, text mining | PubMed |
| The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome. | Cell Commun Signal | 2023 | 37986081 | PubTator, text mining | PubMed |
| IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies. | Front Immunol | 2023 | 37954584 | PubTator, text mining | PubMed |
| Variations of intronic branchpoint motif: identification and functional implications in splicing and disease. | Commun Biol | 2023 | 37949953 | PubTator, text mining | PubMed |
| Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. | Clin Lab | 2023 | 37948498 | PubTator, text mining | PubMed |
| The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling. | Front Oncol | 2023 | 37941547 | PubTator, text mining | PubMed |
| The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China. | Cancer Med | 2023 | 37937729 | PubTator, text mining | PubMed |
| Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. | Nat Genet | 2023 | 37932435 | PubTator, text mining | PubMed |
| Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites. | Proc Natl Acad Sci U S A | 2023 | 37931111 | PubTator, text mining | PubMed |
| Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing. | Blood Res | 2023 | 37926559 | PubTator, text mining | PubMed |
| Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations? | Front Med (Lausanne) | 2023 | 37915324 | PubTator, text mining | PubMed |
| Germline and somatic drivers in inherited hematologic malignancies. | Front Oncol | 2023 | 37904876 | PubTator, text mining | PubMed |
| Indacaterol inhibits collective cell migration and IGDQ-mediated single cell migration in metastatic breast cancer MDA-MB-231 cells. | Cell Commun Signal | 2023 | 37904233 | PubTator, text mining | PubMed |
| Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients. | BMC Pulm Med | 2023 | 37904125 | PubTator, text mining | PubMed |
| Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing. | Nat Genet | 2023 | 37904051 | PubTator, text mining | PubMed |
| Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis. | Int J Mol Sci | 2023 | 37895120 | PubTator, text mining | PubMed |
| R-Loops in Genome Instability and Cancer. | Cancers (Basel) | 2023 | 37894353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=16